Keyword: Eli Lilly

As the psoriatic arthritis field heats up, Novartis has added some new data to its Cosentyx label it hopes can stretch out the drug’s lead.

AbbVie has stored dozens of Humira patents in Bermuda, allowing it to lower its corporate tax rate, according to Reuters.

Shiny statuettes and heart-tugging creative were the rule of the day as we followed pharma marketers and agency leaders into awards night.

Some investors supported resolutions asking for more info about the link between drug prices and executive pay.

Drug rebates and list prices have been on a race to the top, and patients pay up. One solution, per HHS chief Alex Azar? Get rid of rebates entirely.

Endo moved to resolve "all known" testosterone drug lawsuits it faced. The company last year set aside $200 million for the litigation.

A leading position in insulin, combined with new launches like GLP1 drug Victoza, could help Novo grow to DKK19 billion in China by 2025.

The 2-mg dose of Eli Lilly and Incyte's arthritis drug picked up an FDA approval after experts flagged safety concerns on the 4-mg dose.

After learning Aimovig's official price, ICER revised its work to conclude the migraine prevention drug is cost-effective when other options fail.

In a phase 3 study, Novo said oral semaglutide helped diabetes patients manage their blood sugar levels better than Jardiance.